Displaying items by tag: department of cell developmental and integrative biology

Preclinical experiments show how to identify non-responding tumors and improve their response to immunotherapy, using two investigational new drugs that are permitted for human use. Physicians could immediately start investigational research in patients to test the effectiveness of this personalized approach.

Fecal-dominant donor microbes in the recipient patients after fecal microbe transplantation did not correlate with response to anti-PD-1 therapy.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
This 3D-printed anatomical finger model is a low-cost ultrasound training tool for procedural guidance in corticosteroid injections.
This special issue of the Journal of Neuroscience Research puts a spotlight on research by women neuroscientists and the challenges and hurdles they face.
This study used powerful genomic tools and supercomputers to analyze massive amounts of genetic data and identify individual strains within single species of the gut microbiome present during an infant’s first 6 years of life.
UAB’s new cystic kidney disease core center will spearhead a multidisciplinary approach to finding treatments for this devastating disease
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.
UAB and Polish researchers propose that the COVID-19 virus acts as a microRNA “sponge” to deplete miRNA levels in ways that aid viral replication and stymie the host immune response.
Page 1 of 5